General description
Medicine type
Chemical agent
EML status history
First added in 2023
(TRS
1049)
for
Atherosclerotic chronic arterial occlusive disease
Added in 2023
(TRS
1049)
for
Chronic ischaemic heart disease
Added in 2023
(TRS
1049)
for
Cerebral ischaemic stroke
DrugBank
Recommendations
Section
Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease
- Oral > Solid > tablet: 100 mg + 20 mg + 5 mg + 50 mg + 12.5 mg